Eli Lilly (LLY) believes its experimental weight-loss pill could make GLP-1 treatments more accessible worldwide.Read more...
PO Box 276619 Sacramento, Ca 95670
9169999999
techlab@fastmail.com
Copyright © 2023 aicurrent. All Rights Reserved